Nisoldipine

Nisoldipine
	File:Nisoldipine.svg
Systematic (IUPAC) name
	isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Clinical data
Pregnancy; category	US: C (Risk not ruled out) ; ;
Routes of; administration	Oral
Legal status
Legal status	US: ℞-only ;
Pharmacokinetic data
Protein binding	99%
Biological half-life	7-12 hours
Identifiers
CAS Number	63675-72-9
ATC code	C08CA07 (WHO)
PubChem	CID 4499
DrugBank	APRD00635
Chemical data
Formula	C20H24N2O6
Molar mass	388.414 g/mol[[Script error: No such module "String".]]
(verify)

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Nisoldipine (INN) is a calcium channel blocker of the dihydropyridine class. It sold in the United States under the proprietary name Sular.

External links

DDB 30009
Mielcarek J, Grobelny P, Szamburska O (2005). "The effect of beta-carotene on the photostability of nisoldipine". Methods Find Exp Clin Pharmacol. 27 (3): 167–71. doi:10.1358/mf.2005.27.3.890873. PMID 15834448.
Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
Hamilton S, Houle L, Thadani U (1999). "Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure". Heart Dis. 1 (5): 279–88. PMID 11720635.

30px	This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. v d e